From: Acetylsalicylic acid as an adjuvant therapy for schizophrenia
 | Start of run-in | Baseline | 1 Month | 2 Months | 3 Months (@) |
---|---|---|---|---|---|
Informed Consent | X | - | - | - | - |
Screening | X | - | - | - | - |
Pregnancy test | X | - | - | - | - |
Randomization | - | X | - | - | - |
Immunological parameters | X | - | - | X | X |
Blood for DNA isolation | X | - | - | - | - |
Aspirin concentration | - | - | - | X | X |
PANSS | - | X | X | X | X |
CASH (+) | X | - | - | - | - |
Cognitive tests | - | X | - | - | X |
Adverse events | - | - | X | X | X |
Co-medication | X | X | X | X | X |
Compliance | - | X | X | X | X |